Proteomics Method for Studying DNA-Protein Crosslinking Could Shed Light on Cancer Treatment | GenomeWeb

Researchers at the Cross Cancer Institute in Edmonton, Alberta, have come up with a relatively high-throughput way to analyze proteins that have covalently cross-linked to DNA due to radiation exposure.

The research aims to shed light on the cytotoxic effects of radiation used in the treatment of cancer, explained Sharon Barker, the lead author of a study describing the new method that was published in last week's issue of Analytical Biochemistry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.